Belatacept Reactions 1680, p67 - 2 Dec 2017 Varicella zoster virus vasculitis and pneumocystis pneumonia: 2 case reports In a retrospective case control study, two patients [ages not stated; not all sexes stated] were described, who developed varicella zoster virus (VZV) vasculitis and pneumocystis pneumonia each, during treatment with belatacept. The woman who developed VZV vasculitis, died after two months. The patients were switched from calcineurin inhibitors to IV belatacept 5 mg/kg for improved survival following kidney allograft. Belatacept was administered on days 1, 15, 29, 43, 57 and for 28 days thereafter. Sixteen months later, one woman developed cerebral VZV vasculitis, and her belatacept was discontinued. She died of vasculitis, 2 months following belatacept discontinuation. Another patient developed pneumocystis pneumonia 17 months after switching to belatacept and hence, it was discontinued. The patient experienced a graft loss 6 months after belatacept discontinuation [not all outcomes stated]. Author comment: "We reported 2 very serious infectious adverse events, and in one case the patient died from a very rare cerebral VZV complication. . .but larger cohorts are required to evaluate the risks of belatacept used as a rescue strategy." Bertrand D, et al. Belatacept Rescue Therapy in Kidney Transplant Recipients With Vascular Lesions: A Case Control Study. American Journal of Transplantation 17: 2937-2944, No. 11, Nov 2017. Available from: URL: http:// - France 803284155 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 Reactions Weekly Springer Journals


Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
Publisher site
See Article on Publisher Site


You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial